º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Deal struck to produce over 100 million vaccines in the º£½ÇÊÓÆµ for future flu pandemic

The new vaccines would be developed and tested to match the pandemic flu strain circulating at the time

CSL Seqirus is part of a wider group headquartered in Australia(Image: Getty Images)

A Liverpool company has secured a deal to produce over 100 million vaccines in the event of a future flu pandemic.

The º£½ÇÊÓÆµ Health Security Agency (º£½ÇÊÓÆµHSA) has agreed an advance purchase agreement with healthcare company CSL Seqirus.

The firm is already one of the world's biggest flu vaccine manufacturers but the deal would supply the volume of doses needed during a pandemic.

READ MORE: Click here to sign up to the BusinessLive North West newsletter

READ MORE: THG Ingenuity boss on Matthew Moulding, doubling down and shareholder opinions

The º£½ÇÊÓÆµHSA said this is the first time the manufacturing process would be based entirely in the º£½ÇÊÓÆµ, ensuring access to vaccines if the global demand outweighs supply.

In December 2020, º£½ÇÊÓÆµ grandmother Margaret Keenan became the first person in the world to be given the Pfizer Covid-19 jab thanks to agreements made on procuring coronavirus vaccines.

The new vaccines would be developed and tested to match the pandemic flu strain circulating at the time, with the jabs made at CSL Seqirus's existing manufacturing plant in Liverpool.